The FDA issued an alert last Friday that some patients have reported feeling intoxicated after receiving their infusions of the chemotherapeutic drug, docetaxel. The agency will be requiring companies manufacturing docetaxel to more prominently label that the drug solution contains the alcohol found in recreational beverages, known more precisely as ethyl alcohol (or ethanol).

READ FULL ARTICLE Curated publisher From Forbes